KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

ClearPoint Neuro (CLPT) Other Gross PP&E Adjustments (2018 - 2025)

ClearPoint Neuro's Other Gross PP&E Adjustments history spans 12 years, with the latest figure at -$6.0 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments fell 85.51% year-over-year to -$6.0 million; the TTM value through Sep 2025 reached -$6.0 million, down 85.51%, while the annual FY2024 figure was -$1.1 million, 67.05% up from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was -$6.0 million at ClearPoint Neuro, up from -$6.1 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$911000.0 in Q4 2022 and bottomed at -$6.1 million in Q2 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$2.6 million (2021), against an average of -$2.9 million.
  • The largest annual shift saw Other Gross PP&E Adjustments plummeted 702.83% in 2021 before it soared 67.05% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.9 million in 2021, then surged by 51.95% to -$911000.0 in 2022, then crashed by 275.74% to -$3.4 million in 2023, then skyrocketed by 67.05% to -$1.1 million in 2024, then plummeted by 427.93% to -$6.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Other Gross PP&E Adjustments are -$6.0 million (Q3 2025), -$6.1 million (Q2 2025), and -$3.0 million (Q1 2025).